FI
NBIX icon

Fosun International’s Neurocrine Biosciences NBIX Stock Holding History

Fosun International’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-118,323
Closed -$9.75M – 271
2019
Q2 		$9.75M Buy
118,323
+17,000
+17% +$1.4M 0.64% 23
2019
Q1 		$8.67M Buy
101,323
+39,000
+63% +$3.26M 0.55% 26
2018
Q4 		$4.41M Buy
62,323
+19,223
+45% +$1.84M 0.26% 48
2018
Q3 		$5.19M Buy
+43,100
New +$4.89M 0.25% 46

Other funds holding NBIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fosun International's NBIX Position: Q3 2019 in Review

Fosun International sold out of Neurocrine Biosciences (NBIX) in Q3 2019, closing a stake of 118,323 shares — an estimated $9.75M sold.

Fosun International first reported a position in NBIX in Q3 2018 and held it in 4 quarters. The position peaked at $9.75M in Q2 2019. 332 funds tracked by Wall St. Rank hold NBIX as of Q3 2019.

  • Fosun International reported no remaining Neurocrine Biosciences position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 118,323 Neurocrine Biosciences shares in Q3 2019, an estimated $9.75M.
  • Fosun International first reported a position in Neurocrine Biosciences in Q3 2018 and held it in 4 quarters.
  • Fosun International's Neurocrine Biosciences position peaked at $9.75M in Q2 2019.
  • 332 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.